MaxPro Medical
MaxPro Medical
Advanced diagnostic and monitoring equipment for professional and home healthcare.
The global demand for Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) systems is surging, driven by an aging population and increasing prevalence of metabolic disorders. As a specialized OEM/ODM manufacturer, we bridge the gap between high-tech R&D and mass-market accessibility.
Integration of AI-driven data analytics and Bluetooth connectivity is the new standard. Our factory focuses on "Smart Diagnostics," ensuring that every glucose tester is not just a sensor, but a data point in a broader digital health ecosystem.
Post-pandemic healthcare focuses on decentralization. Home-based monitoring devices are now essential. We provide robust industrial supply chains to ensure healthcare providers never face stock-outs of life-critical monitoring tools.
Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. With a strong commitment to innovation, quality, and customer satisfaction, we provide reliable healthcare technologies to over 500 healthcare institutions and distributors worldwide.
Our company operates a modern 20,000 sq ft manufacturing facility equipped with advanced production and testing systems. Certified under ISO 13485 quality management standards, all of our products comply with international medical regulations, with key products receiving FDA 510(k) clearance and CE certification.
From PCBA design to final clinical validation, we offer full-spectrum customization.
Utilizing high-conductive gold or silver electrodes on test strips to ensure CV (Coefficient of Variation) is consistently below 5%, meeting strict ISO 15197:2013 standards.
Custom SDK/API development for seamless data sync with hospital HIS systems or consumer health apps, ensuring HIPAA-compliant data transmission.
Industrial design services that balance medical ergonomics with modern aesthetics, providing your brand with a unique market identity.
Navigating the complex regulatory landscape of international medical trade.
We are investing in R&D for spectroscopic and interstitial fluid-based non-invasive monitoring to revolutionize the user experience.
Moving from "What is my sugar now?" to "What will it be in 2 hours?" through deep learning algorithms integrated into our next-gen meters.
Developing biodegradable test strips to reduce medical waste, aligning with global ESG (Environmental, Social, and Governance) goals.
Expert insights into blood glucose manufacturing and partnership.
